Companies › MPLT

MAPLIGHT THERAPEUTICS INC (MPLT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001770069 · EDGAR filings · Updated 2026-07-28

MAPLIGHT THERAPEUTICS INC (MPLT) has reported institutional ownership of 58.2%, with 81 institutional managers holding positions valued at $502.2M per the latest 13F reporting period.

Filings this week (2)

• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Insider transaction reported (Form 4)
• 2026-07-20 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MAPLIGHT THERAPEUTICS INC has 81 institutional holders and institutional ownership of 58.2%.

Insider activity

Insiders reported 47 transactions (6 buys, 13 sells) across 13 reporting insiders, with a net reported value of $108.0M.

Related companies

PRECIGEN (PGEN) · BRIDGEBIO ONCOLOGY THERAPEUTIC (BBOT) · COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS (CMPS) · BETA BIONICS INC (BBNX) · MINIMED GROUP INC (MMED) · SANA BIOTECHNOLOGY INC (SANA)